GemmaCert

About:

GemmaCert is developing a non-destructive and noninvasive analytical cannabis-testing technology for professional and home use.

Website: http://gemmacert.com/

Twitter/X: gemmacert

Top Investors: Hebrew University of Jerusalem, Neo Ventures, Stony Hill Corp, Agrinnovation, Arba Finance Ltd.

Description:

GemmaCert is a smart solution for testing cannabis potency, which unlike other solutions, is simple and sleek, for everyday use, requiring no specific skill-set for operation, and whose form gives little indication to the sophistication of the technology working underneath. GemmaCert is a bridge between technology and nature. This design created the desired attractive and useful man-machine interface for the best possible user experience along with a well-defined product with aesthetic presence without sacrificing on performance. GemmaCert is making a name for high performance, robustness, ease-of-use and reliability. No cannabis flower is the same, so before anyone consumes cannabis, they should have an understanding exactly what is in it and how it may affect them. From pharmacies in Germany, coffeeshops in Amsterdam, to supply chain stakeholders in North America, GemmaCert brings certainty and confidence to cannabis professionals, as well as consumers and patients worldwide. After over two years in research and development, GemmaCert started delivering first units to customers worldwide, primarily in North America and Europe. Revenues are generated from device sales and monthly subscription fees to our analytical service since GemmaCert units are operated and upgraded via secure cloud-based servers.

Total Funding Amount:

$9.63M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Ra'anana, HaMerkaz, Israel

Founded Date:

2015-06-15

Contact Email:

info(AT)gemmacert.com

Founders:

Guy Setton

Number of Employees:

11-50

Last Funding Date:

2021-01-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai